deltatrials
Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06849128

NeuroReAlign Therapy for Cognitive Rehabilitation in Patients with Stroke

Effects of NeuroReAlign Therapy on Cognition in Patients with Stroke: a Randomized Controlled Trial

Sponsor: Middle East University

Conditions Stroke
Updated 2 times since 2025 Last updated: Mar 13, 2025 Started: Mar 15, 2025 Primary completion: Apr 15, 2025 Completion: Apr 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06849128, this NA trial focuses on Stroke and remains actively recruiting participants. Sponsored by Middle East University, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – present · 17 months · monthly snapshotNot Yet Recruiting

Change History

2 versions recorded
  1. Apr 2025 — Present [monthly]

    Not Yet Recruiting NA

  2. Mar 2025 — Apr 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Middle East University
Data source: Middle East University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.